Email updates

Keep up to date with the latest news and content from AIDS Research and Therapy and BioMed Central.

Open Access Highly Accessed Open Badges Research

Highlights from the 2014 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the end of the HIV pandemic

Alain Lafeuillade1*, Mark Wainberg2, Marie-Lise Gougeon3, Sabine Kinloch-de Loes4, Philippe Halfon5 and Hervé Tissot-Dupont6

Author Affiliations

1 Department of Infectious Diseases, General Hospital, Toulon, France

2 McGill University, Montreal, Canada

3 Antiviral Immunity, Biotherapy and Vaccine Unit, Infection and Epidemiology Department, Pasteur Institute, Paris, France

4 Royal Free Center for HIV Medicine, Department of Infection and Immunity, Royal Free Hospital, London, UK

5 Internal Medicine and Infectious Diseases Department, European Hospital and Alphabio Laboratory, Marseille, France

6 Health Department, Research Institute for Development, Marseille, France

For all author emails, please log on.

AIDS Research and Therapy 2014, 11:28  doi:10.1186/1742-6405-11-28

Published: 21 August 2014


The 2014 International Symposium on HIV and Emerging Infectious Diseases (ISHEID) provided a forum for investigators to hear the latest research developments in the clinical management of HIV and HCV infections as well as HIV cure research. Combined anti-retroviral therapy (c-ART) has had a profound impact on the disease prognosis and transformed this infection into a chronic disease. However, HIV is able to persist within the infected host and the pandemic is still growing. The main 2014 ISHEID theme was, hence “Together for a world without HIV and AIDS”. In this report we not only give details on this main topic but also summarize what has been discussed in the areas of HCV coinfection and present a short summary on currently emerging viral diseases.

HIV; HCV; Hepatitis E; Antiretroviral drugs; HIV vaccine; HIV cure; HIV reservoirs